국내 제약기업의 연구개발비 및 마케팅 비용이 기업성과에 미치는 영향 연구

• 영문명: The Effects of R&D Investment and Marketing Expenses on the Performance of Korean Pharmaceutical Companies
• 발행기관: 대한약학회
• 저자명: 정재은(Jae Eun Jung) 강민구(Minku Kang) 방준석(Joon Seok Bang)
• 간행물 정보: 『약학회지』제63권 제4호(2019년), 204~213쪽, 전체 10쪽
• 주제분류: 의약학 > 기타의약학
• 파일형태: PDF
• 발행일자: 2019.08.30

영문 초록

Abstract The purpose of this study was to investigate the effect of R&D investment and marketing expenses on the performance of the Korean pharmaceutical companies. The top-ranked forty companies in Korea were selected and the 6-year-long data were analyzed to obtain the correlations among R&D intensity, marketing expenses, growth rate, operating profitability. In addition, the differences between innovative and non-innovative pharmaceutical companies were also examined. Both the amount and the ratio of R&D investment over sales activities were significantly higher in the innovative pharmaceutical companies compared with the non-innovative pharmaceutical companies. In these competitive circumstances, R&D investment is indispensable for the sustainable growth in pharmaceutical companies. In conclusion, Korean pharmaceutical companies as well as government bodies should focus on more intensive and strategic R&D activities to increase the capabilities for developing innovative new products and future prosperity.

목차

서 론(Introduction)

연구방법(Research Methods)

결 과(Results)

고 찰(Discussion)

결 론(Conclusion)

키워드

Pharmaceutical company R&D investment marketing expense company performance sales growth rate operating profit